Navigation Links
Para 12 Plus Retics 5-Part Differential Control

ProductsPara 12 Plus Retics 5-Part Differential Control
Company Streck
Item Para 12 Plus Retics 5-Part Differential Control
Features 
Description Para 12 Plus Retics is a 5-part differential control that controls all parameters, including reticulocytes, for the Abbott CELL-DYN 3200, 3500, 3700 and 4000 instruments. Para 12 Plus Retics also contains nucleated red blood cells that can be analyzed and enumerated by the CELL-DYN 4000. The assay contains automated and manual reticulocyte values for all three levels. The user need only purchase, inventory and manage quality control records for one control. This unique product has seven-day open-vial stability, 75-day closed-vial stability and is available in low, normal and high levels. The control is available in a 3.5ml vial with a pierceable cap for automated sampling. Assay disk available.
Info Streck
Customer Service: (800) 228-6090
Web site: http://www.streck.com/default.asp

Related medicine products :

1. STaK-Chex Plus Retics 5-Part Differential Control
2. CBC with Platelet Count & Automated Differential
3. Manual Differential
4. STaK-Chex White Cell Differential Control
5. Para 5X Whole Blood Hematology Control, Five-part Differential
6. Para 12 Extend Whole Blood Hematology Control, Three-part Differential
7. Para 12 Whole Blood Hematology Control, Three-part Differential
8. Endoalpha Centralized O.R. Control System
9. Cruise Control
10. US Autoflow Single Chamber Stackable Water-Jacketed CO2 Inc.w/ Humidity Display and Control
11. Fluid Control 2203
... is a powerful, portable, hand-held digital magnifier ... size of a computer mouse, Max connects ... seconds, allowing you to read newspapers, magazines, ... print on any surface curved or straight. ...
... a superior full-color, auto-focus, desktop video magnifier. ... mind, Merlin enables the user to view ... high contrast positive or high contrast negative. ... optional feature enables the user to use ...
... Thelco general purpose incubators ... temperature control and uniformity required ... applications. These versatile microprocessor controlled ... selection, an easy-to-read digital display, ...
... Thelco general purpose incubators designed ... control and uniformity required for ... These versatile microprocessor controlled incubators ... an easy-to-read digital display, and ...
Medicine Products:
(Date:6/28/2017)... ... June 28, 2017 , ... Continually at the forefront of ... Drops™ have received the Non-GMO Project Verified seal. All five flavors of the ... only third-party verification for non-GMO foods and products in North America. , Available ...
(Date:6/28/2017)... Pekin, IL (PRWEB) , ... June 28, 2017 , ... ... research shows that every 62 minutes, at least one person dies as a direct ... grows, a greater need exists for qualified treatment providers. The iaedp Foundation meets this ...
(Date:6/28/2017)... ... June 28, 2017 , ... Canadian Zeolite Corp. (the “Company”) ... year study conducted by the University of Saskatchewan in partnership with PotashCorp, Agrium ... brine-impacted groundwater. As a part of the study, batch adsorption experiments were conducted ...
(Date:6/27/2017)... Fla. (PRWEB) , ... June 27, 2017 , ... ... today announced the appointment of Mike Finnegan to the position of Executive Vice ... years of experience in healthcare technology, telehealth and medical device sales leadership. He ...
(Date:6/27/2017)... ... 27, 2017 , ... The Congressional Budget Office (CBO) projects that the Better ... Patient Protection and Affordable Care Act (ACA), would result in 22 million Americans losing ... law. , More than 20 million Americans have gained health insurance under the ACA, ...
Breaking Medicine News(10 mins):
(Date:6/13/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... the U.S. Food and Drug Administration (FDA) has notified the ... to its Zhejiang, China manufacturing facility ... "The successful clearance of the Warning Letter related to our ... a measure of the progress we have made in our ...
(Date:6/11/2017)...  Eli Lilly and Company (NYSE: LLY ) ... of galcanezumab, an investigational treatment for the prevention of ... key secondary endpoints for galcanezumab compared to placebo at ... EVOLVE-2 and REGAIN) will be presented today at the ... Boston . "The detailed ...
(Date:6/9/2017)... Calif. , June 9, 2017 AirXpanders, ... company focused on the design, manufacture, sale and distribution ... market on the progress of its commercial roll-out in ... now available in more than one hundred (100) medical ... AeroForm offers a needle-free alternative for women ...
Breaking Medicine Technology: